Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
Condition: Hemorrhagic Fever, Ebola Interventions: Biological: Ad26.ZEBOV; Biological: MVA-BN-Filo Sponsors: Janssen Vaccines & Prevention B.V.; Bavarian Nordic GmbH Recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2016 Category: Research Source Type: clinical trials
Open Study of the Duration of Immunity After Vaccination With GamEvac
Condition: Hemorrhagic Fever, Ebola Intervention: Procedure: blood sampling collection Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2016 Category: Research Source Type: clinical trials
Partnership for Research on Ebola VACcinations
Condition: Ebola Virus Disease Interventions: Biological: Ad26.ZEBOV; Biological: MVA-BN-Filo; Biological: rVSVΔG-ZEBOV-GP; Biological: Placebo; Biological: rVSV boost Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); The Liberia-US Clinical Trials Partnership Program, Partnership for Research on Ebola Virus in Liberia Project (PREVAIL); Institut National de la Santé Et de la Recherche Médicale, France; London School of Hygiene& Tropical Medicine (LSHTM) Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2016 Category: Research Source Type: clinical trials
